Structural constraints derived from different antibody epitopes on human growth hormone (hGH) were used to screen three-dimensional models ofhGH that were generated by computer algorithms. Previously, alanine-scanning mutagenesis deflned the residues that modulate binding to 21 different monoclonal antibodies to hGH. These functional epitopes were composed of 4-14 side chains whose a-carbons clustered within 4-23 A. Distance and topographic constraints for these functional epitopes were virtually the same as constraints derived from known x-ray structures of proteinantigen complexes. The constraints were used to evaluate about 1400 models of hGH that were computer-generated by a secondary-structure prediction and packing algorithm. On average each functional epitope reduced the number of models in the pool by a factor of 2, so that 8 monoclonal antibodies could reduce the number of possible models to <10. The average root-mean-square deviation of a-carbon coordinates between the x-ray structure and either the pool of starting models or final models ranged from 13 to 16 A or 4 to 7 A, respectively, depending on the pool of starting models and the level of constraints imposed. AU of the rmal models had the correct folding topography, and the best model was within 3.8 A root-mean-square deviation of the x-ray coordinates. This model was as close as it could have been because the models were built by using ideal helices and those in the x-ray structure are not. Our studies suggest that epitope mapping data can effectively screen structural models and, when coupled to predictive algorithms, can help to generate low-resolution models of a protein. features of a protein. In some cases fluorescence energy transfer (5) and disulfide mapping or crosslinking (e.g., see ref. 6) can provide some information on tertiary structure. However, these methods are very limited and for the most part do not provide enough high-resolution distance constraints to define the overall tertiary structure of a protein.
models or final models ranged from 13 to 16 A or 4 to 7 A, respectively, depending on the pool of starting models and the level of constraints imposed. AU of the rmal models had the correct folding topography, and the best model was within 3.8 A root-mean-square deviation of the x-ray coordinates. This model was as close as it could have been because the models were built by using ideal helices and those in the x-ray structure are not. Our studies suggest that epitope mapping data can effectively screen structural models and, when coupled to predictive algorithms, can help to generate low-resolution models of a protein.
The only established methods for obtaining three-dimensional structural information for a novel protein fold are x-ray crystallography or multidimensional NMR spectroscopy. Both methods have their inherent limitations, because some proteins are very difficult to crystallize and some are too large to be solved by NMR methods. Thus, there is a great deal of interest in predicting protein structure de novo (for review, see ref. 1) . Unfortunately, predictive methods are not especially reliable. For instance, secondary-structure predictive methods have an accuracy of c75% (for review, see ref.
2). If secondary structure is known, it is possible to generate rudimentary three-dimensional models by packing all possible arrangements of secondary structural units and selecting those that are most compact (3) . However, this method produces many possible three-dimensional models and additional computational methods cannot accurately sort between the alternative models.
Biochemical and spectroscopic methods have been used to try to evaluate predicted models. For example, circular dichroism (for review, see ref. 4) , infrared, and Raman spectroscopy are useful to establish the secondary structural
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features of a protein. In some cases fluorescence energy transfer (5) and disulfide mapping or crosslinking (e.g., see ref. 6 ) can provide some information on tertiary structure. However, these methods are very limited and for the most part do not provide enough high-resolution distance constraints to define the overall tertiary structure of a protein.
Previously, the epitopes on human growth hormone (hGH) for binding 21 different monoclonal antibodies (mAbs) were mapped by alanine-scanning mutagenesis (7) . The set of alanine substitutions that reduced binding affinity to a given mAb by >2-fold we called the functional epitope for that antibody. Each functional epitope contained a unique set of residues which were often distant in primary sequence but were brought together to form a patch on the protein surface (e.g., see Fig. 1 ). Thus, residues that bind a mAb are subject to certain structural constraints that could be applied to define the folding of the molecule.
Here, we derive average structural constraints defined by the antibody epitope mapping data and use them to screen computer-generated models of hGH. It was important to test this screening procedure on a protein of known structure so that the functional data could be calibrated and the predicted and known structures could be compared. Indeed, the mAb screening procedure identified the models that best matched the structure of hGH.
METHODS
Derivation of Structural Constraints from Functional Epitopes. The functional epitopes for each of the 21 different anti-hGH mAbs consisted of 4-14 residues (average, 8) (7). The a-carbon coordinates for functional residues within each epitope clustered within 4-23 A and were separated from the other functional residues by an average distance of 12 A ( Fig.   2A) . We analyzed the structures of the three antibodylysozyme complexes deposited in the Brookhaven Protein Data Bank [1FDL(D1.3) (8) , 2HFL(HYHEL-5) (9), and 3HFM(HYHEL-10) (10) ] to see how the distance between residues in the functional epitopes in hGH compared with the contact epitopes from lysozyme. The contact epitopes were defined as those side chains that come within 4 A (van der Waals contact) of the antibody. The intraresidue distances between the a-carbons of the contact side chains ranged from 4 to 24 A (Fig. 2A) . Thus, the extreme dimensions of the patches for the structural and functional epitopes are comparable.
In addition to defining distance constraints within each functional epitope, it was necessary to define topographic constraints because the functional residues are assumed to cluster on the surface and on the same side of the protein. We evaluated the span angle for the 21 functional epitopes in hGH and found that the average span angle between functional residues was -350, although some were as large as 1000 (Fig. 2B) . We conducted a similar analysis of lysozymeantibody complexes and found a similar range of span angles for contact residues in lysozyme (Fig. 2B) .
Generation of Model Structures of hGH. Structural models of hGH were generated in two steps (11) . First, the units of secondary structure were defined either based on the x-ray coordinates of hGH in the complex of hGH with the extracellular domain of its receptor, also called the hGH-binding protein, hGHbp [hGH(hGHbp)2] (12), as a test case, or by a secondary-structure prediction algorithm (13) . The predicted helical regions overlap those in the x-ray structure but deviated at the ends (Table 1) . Although many of the functional residues are in loops connecting the helices (7), loop structures were difficult to predict (14) and we made no attempt to model them.
In the second step, 7 x 107 three-dimensional models were generated with an algorithm described by Cohen et al. (3) with either the actual or predicted helices (called group I or group II models, respectively; Table 1 ). Models in group I or II contained a variety of four helix assemblies that differed in overall folding topography, precise helix-helix crossing angles, and packing interactions. We treated residues outside the helical regions as connecting loops. Structures which could not possibly be connected by extending the loops or models which sterically overlapped were eliminated. The remaining models were screened for the most acceptable helix-helix packing (3) . Approximately 1400 final models remained in groups I and II.
Screening of Structural Models. Of the 21 different functional epitopes, 8 antibodies were selected for screening that had nonoverlapping functional epitopes (Table 2) . Together these epitopes covered the majority of the accessible surface of hGH, and each contained at least two functionally important residues in two different helical regions.
A computer program, PICKMODEL, was developed to apply the distance constraints derived from the functional epitopes.
A distance matrix that contained the a-carbon distances between the functional residues within each epitope on hGH was calculated for each model. If any one of the distances fell outside the imposed range, the model was discarded. For example for mAb 2, residues 8 and 112 are located in helical regions ( Fig. 1 ; Table 2 ). Models would be discarded if the residues were separated by <4 A or >20 A (for highstringency constraints) or >24 A (for low-stringency constraints). All the models that survived the first epitope selection were automatically screened for compatibility with the next epitope until structural data from all 8 epitopes were used. Functional residues are defined as those that when converted to alanine cause 22-fold reduction in affinity for the indicated mAb. Residues in italics are those present in one of the four a-helices.
The models that survived the distance constraint selection then were screened with the topographic constraints derived from the functional epitopes by the program TOPO. In this program, the span angles for each pair of residues within helical regions of a functional epitope were calculated for each model. A model was discarded if any one of the span angles was >1200. RESULTS Group I Models. Group I models contained helices derived from the crystal structure ofhGH to determine whether it was possible to recover structures that resembled the hGH fold from the packing algorithm previously described (3). Initially we applied a relaxed set of constraints (distances between a-carbon atoms of functional residues, <24 A; span angles, <1200). Beginning with 1388 models, the distance constraints from each of the eight functional epitopes reduced the number of surviving models by about 2-fold, so that 45 models remained (Table 3) . Topographic constraints from the functional epitopes further reduced the number of models to 19. Topographic constraints from mAbs 2 and 9 were most effective whereas those derived from the other mAbs were redundant to the distance constraints already imposed. The average RMSD for main-chain atoms between these 19 models and the crystal structure of hGH was 7.0 A (range, 3.8-9.2 A). This was considerably lower than for starting models (average RMSD, 13.8 A; range, 3.8-15.5 A).
The same screening procedure was repeated with tighter distance constraints (4-20 A) to test how this affected the sorting (Table 3 ). This was justified because =95% of the functional residues in each of the 21 functional epitopes lie within 20 A ofeach other. With these conditions, 1388 models were reduced to 6 models having an average RMSD of 5 A from the x-ray structure. Additional topographic constraints reduced these to 4 models having an average RMSD of 4.2 A (range, 3.8-4.6 A). The largest RMSD between these four models was 2.5 A. Thus, tighter distance constraints made for a more stringent screen, and the additional topographic constraints were not as important.
The remaining 4 models were a subset of the 19 structures found in the low-stringency screen. All had the same overall fold as hGH; that is, helices 1 and 2 were parallel to each other but antiparallel to helices 3 and 4. They had similar folds except that the registration of the helices relative to one another and the packing angles were not the same. The best predicted model (3.8 A RMSD from hGH) is compared with hGH in Fig. 3A .
Group H Models. In this group, all the helices were predicted de novo (Table 1 ) from a segment-based patternmatching approach (13) . A library of =108 randomly packed bundles was sorted for optimal packing (3), which reduced the number of models to 1361 (Table 4) . By using the more stringent distance constraints the library was reduced to 10 models after applying constraints from just five mAbs. None of the models survived constraints imposed by the remaining three mAbs. This was not due to overselection by any one mAb in particular; in each case some of the 1361 models survived selection by a single mAb (data not shown).
To obtain the best model in this set we relaxed the maximum distance constraint in steps of 1 A unit until some models survived screening by all the mAbs. We found that at a constraint of 4-23 A, 5 models survived screening by all eight functional epitopes (Table 4) . Additional topographic constraints reduced the number of models to 4. The average RMSD of these was 5.8 A (range, 5.81-5.85 A), and the greatest deviation between any two of them was 3.5 A RMSD. They all had similar helical packing and folds to hGH and were the best models among those in group II. The best model from this screen is compared with hGH in Fig. 3B .
DISCUSSION
The focus of this work has been to develop a set of structural constraints and algorithms to evaluate the use of functional Group I models were generated by randomly packing helices defined by the x-ray coordinates (ref. 12 ; Table 1 ) and sorting them by compactness (3, 13) . The remaining 1388 models were screened first by using distance constraints from 8 mAbs and next by using corresponding topographic constraints (indicated as T-2 and T-9 for mAbs 2 and 9, respectively). Topographic constraints from the other mAbs did not further reduce the number of models at this stage of the screening. The average root-mean-square deviation (RMSD) relative to the structure of hGH for the surviving models was calculated after sorting by each mAb. Models were screened by using distance constraints of either 4-24 A or 4-20 A and span-angle constraints of <1200 between functional residues in a-helices ( data from epitope mapping studies to screen structural models. It was necessary to evaluate many functional epitopes on a known structure to generate consensus distance and topographic constraints from antibody binding data.
Two pieces ofevidence suggest that the consensus distance and topographic constraints derived from the 21 different anti-hGH mAbs will apply to most mAb functional epitopes. (i) The constraints from x-ray analysis of the three lysozymeantibody complexes are in good agreement with those derived from the hGH functional epitopes (Fig. 2) . That is, the average distance between any two functional or contact residues on the antigen is -12 A (range, 4-23 A) and the average span angle is -35°(maximum, 1200). (ii) The distances and span angles between functional residues from the 21 mAbs in the data base exhibit Gaussian distribution. The average number of contact side chains in lysozyme (15 side chains) is about twice the average number of side chains that constitute the functional epitopes in hGH (8 side chains). We believe that this is because not all contact residues are functionally important in binding affinity (7, (15) (16) (17) .
Optimizing the constraints is critical for accurate and thorough screening of structural models. For example, decreasing the maximum distance constraint reduced the number of surviving models in groups I and II dramatically (Tables 1 and 2 ). In fact, once the maximal distance constraint between functional residues was decreased to 20 A, there was no additional value to the topographic screen, because the topographic and distance constraints become redundant when the distance between functional surface residues is small. In fact, if one reverses the order of screening by applying the topographic constraints first, followed by the distance constraints, then the topographic information is as effective as the distance information in screening the models (data not shown). We do not think it is reasonable to tighten the distance constraints below 20 A without independent evidence that the functional epitope is unusually small. It is interesting that each epitope consistently eliminated the number of models by a factor of 2-3 (Tables 3 and 4 ). This may be because each functional epitope recognized determinants from two different helices which by our distance constraints can cover nearly half of the molecule. Some mAbs caused much larger apparent reductions in the number of surviving models than other mAbs (such as mAb 10 with model group I or mAbl4 with model group II). Generally, this is not so much a feature of these mAbs as it is a function ofthe order the mAb is used in the screening. For example, if these mAbs are moved to the end of the screen they are not nearly as effective as at the beginning (data not shown), because other mAbs in front of them contain redundant information.
It is also possible to score the models based on how well the set of functional residues for each model fits the observed distance and topography distributions (Fig. 2) . In fact, the Group II models were generated and screened as described for group I models in Table 3 except that a-helices were predicted de novo (Table 1) . Models were selected by using distance constraints of either 4-20 A or 4-23 A and span angles of <1200. Topographic constraints from mAbs 1,4, 9, 10,14,17, and 19 did not further reduce the number of surviving models after imposition of distance constraints from all 8 mAbs and topographic constraints from mAb 2 (T-2).
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Proc. Natl. Acad. Sci. USA 91 (1994) average distance between functional residues in the poor models was higher than for good models, but the difference varied depending on the mAb used (data not shown). While this can be of use in scoring the models, we found that the simple limit constraints were easier to apply and were effective.
The set of group I models with helices defined from the x-ray coordinates were generated to test the ability of the packing algorithm to produce models like hGH and the ability of the functional epitopes to screen them. When the actual hGH model was added to the 1400 starting models, it survived screening under the most stringent constraints by all the antibodies (data not shown). Moreover, all surviving models that were screened under the most stringent conditions were ones that had similar folds and topography to hGH and were the best models in the starting set. Thus, the screening technique does not remove models that resemble the actual protein; it removes those that do not resemble the protein.
The best group I model that survived the screening procedure was still 3.8 A RMSD from the actual hGH model (Fig.  3A) . The primary reason for this is that the a-helices were assumed to be ideal, when in fact helix 2 is bent and there are additional imperfections near the ends of the other helices. Even if the helical orientation and registration were correct, the closest we could align an idealized helical model to hGH is 3.8 A RMSD. In addition, there were -108 starting models, and this was not enough to test every possible helical orientation, pitch, and registration. Thus, it is quite remarkable that the models recovered were as close to hGH as they turned out to be.
We generated group II models to test the ability of the secondary and tertiary predictive methods to generate hGHlike structures de novo and screen them with the functional epitopes. The models were efficiently screened but the best models left were 5.8 A RMSD from hGH. All had the same helical topography as hGH. However, because of additional inaccuracies in the predicted helical regions the models were less accurate than those surviving in group I (Tables 3 and 4 ; Fig. 3 ). Whether or not the de novo predictive algorithm (3, 13 ) is applicable to proteins other than this helical class has yet to be determined. Nonetheless, these studies show that it is possible to produce low-resolution structural models by screening the de novo predicted sets of models with the functional epitopes.
The generation of functional epitopes for proteins ( (19) . mAbs react with surface residues which are almost always discontinuous in nature. Thus, from high-resolution epitope mapping data one will obtain information about the tertiary fold of the protein.
Although we have focused on screening models from semior completely de novo predictions, the constraints and screening procedure devised should be applicable to a number of other model-building exercises. For example, a functional epitope could distinguish the chain direction or connectivity in a situation where the trace of the polypeptide through an electron density map was ambiguous. Functional epitopes can be useful for verifying homology models of proteins and even ones which are generated from very remote sequence analysis. For example, Bazan (20) predicted that the cytokine receptor superfamily of receptors would mimic an immunoglobulin fold. When the functional epitope for binding of hGH to its receptor (a member of the cytokine superfamily) was mapped upon the predicted folding diagram, the functionally important residues clustered to one side of the model (21) . Subsequent structural determination confirmed the basic immunoglobulin fold of the molecule (12) . In another, more recent example, epitope mapping data allowed the generation of a low-resolution model of clathrin (22) . Baldwin (23) has suggested a number of possible and probable arrangements of a-helices in seven-transmembrane receptors. Epitope mapping data could be very useful in screening these models because it is very difficult to obtain high-resolution x-ray diffraction data for these receptors.
